Seely Lynn
SEC CIK 1327111 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | Pres, CEO, Dir | 63.9K | $106.8K | $437.9K | 13 | 2024-02-09 | 2026-08-21 |
Most active insiders at LYEL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ARCH Venture Partners IX Overage, L.P. | 10% | $12.50M | — |
| 2 | BERNS PAUL L | 10% | $12.50M | — |
| 3 | Seely Lynn | Pres, CEO, Dir | — | $353.1K |
| 4 | Bulis Veronica Sanchez | VP, Corp. Ctrl | — | $96.9K |
| 5 | Lee Gary K. | CSO | — | $71.7K |
| 6 | Hill Stephen J. | COO | — | $51.3K |
| 7 | Shook David | Chief Medical Off | — | $31.3K |
| 8 | Innovative Cellular Therapeutics Holdings Ltd | 10% | — | $274.30 |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-25 16:06 | 2026-08-21 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Pres, CEO, Dir | S - Sale | $15.54 | -9,589 | 63.9K | -13% | -$149.0K | |
| 2026-08-11 16:07 | 2026-08-10 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Pres, CEO, Dir | S - Sale | $14.34 | -390 | 73.5K | -0.5% | -$5,593 | |
| 2026-06-15 18:37 | 2026-05-11 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Pres, CEO, Dir | S - Sale | $18.91 | -388 | 73.9K | -0.5% | -$7,337 | |
| 2026-02-12 | 2026-02-11 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Pres, CEO, Dir | S - Sale | $23.39 | -7,455 | 74.3K | -9% | -$174.4K | |
| D | 2026-02-11 | 2026-02-09 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Pres, CEO, Dir | A - Grant | $0.00 | +20.0K | 82.2K | +32% | $0 |
| D | 2026-02-11 | 2026-02-10 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Pres, CEO, Dir | S - Sale | $23.12 | -438 | 81.7K | -0.5% | -$10.1K |
| 2025-11-12 | 2025-11-10 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Pres, CEO, Dir | S - Sale | $16.11 | -412 | 67.2K | -0.6% | -$6,637 | |
| 2025-08-22 | 2025-08-20 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Pres, CEO, Dir | A - Grant | $0.00 | +40.0K | 74.8K | +115% | $0 | |
| 2025-08-22 | 2025-08-21 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Pres, CEO, Dir | S - Sale | $10.54 | -7,257 | 67.6K | -10% | -$76.5K | |
| M | 2025-08-13 | 2025-08-11+ | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Pres, CEO, Dir | S - Sale | $10.43 | -797 | 35.2K | -2% | -$8,315 |
| 2025-03-18 | 2025-03-14 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Pres, CEO, Dir | P - Purchase | $0.61 | +175.0K | 712.5K | +33% | +$106.8K | |
| D | 2025-02-26 | 2025-02-10 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Pres, CEO, Dir | A - Grant | $0.00 | +337.5K | 537.5K | +169% | $0 |
| 2024-02-13 | 2024-02-09 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Pres, CEO, Dir | A - Grant | $0.00 | +200.0K | 200.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations